TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.400
+0.040 (0.92%)
Jul 17, 2026, 9:42 AM EDT - Market open
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $270.23 million as of July 17, 2026. Its market cap has increased by 51.63% in one year.
Market Cap
270.23M
Enterprise Value
245.71M
1-Year Change
51.63%
Ranking
Category
Stock Price
$4.40
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $270.23M, a decrease of -17.80%. That is a compound annual growth rate of -3.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 270.23M | -22.51% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Electromed | 354.39M |
| Perspective Therapeutics | 336.44M |
| Standard BioTools | 334.74M |
| CapsoVision | 319.27M |
| Treace Medical Concepts | 287.39M |
| Sight Sciences | 282.93M |
| 908 Devices | 280.20M |
| Senseonics Holdings | 268.32M |